R. Ono, T. Masaki, Franklin Mayca Pozo, Y. Nakazawa, S. Swagemakers, E. Nakano, W. Sakai, Seiji Takeuchi, F. Kanda, T. Ogi, P. Spek, K. Sugasawa, C. Nishigori
{"title":"通过全基因组测序诊断为轻度色素性补体D组干皮病的儿童10年随访","authors":"R. Ono, T. Masaki, Franklin Mayca Pozo, Y. Nakazawa, S. Swagemakers, E. Nakano, W. Sakai, Seiji Takeuchi, F. Kanda, T. Ogi, P. Spek, K. Sugasawa, C. Nishigori","doi":"10.1111/phpp.12240","DOIUrl":null,"url":null,"abstract":"Most patients with xeroderma pigmentosum complementation group D (XP‐D) from Western countries suffer from neurological symptoms, whereas Japanese patients display only skin manifestations without neurological symptoms. We have previously suggested that these differences in clinical manifestations in XP‐D patients are attributed partly to a predominant mutation in ERCC2, and the allele frequency of S541R is highest in Japan.","PeriodicalId":20060,"journal":{"name":"Photodermatology","volume":"22 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":"{\"title\":\"A 10‐year follow‐up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole‐genome sequencing\",\"authors\":\"R. Ono, T. Masaki, Franklin Mayca Pozo, Y. Nakazawa, S. Swagemakers, E. Nakano, W. Sakai, Seiji Takeuchi, F. Kanda, T. Ogi, P. Spek, K. Sugasawa, C. Nishigori\",\"doi\":\"10.1111/phpp.12240\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Most patients with xeroderma pigmentosum complementation group D (XP‐D) from Western countries suffer from neurological symptoms, whereas Japanese patients display only skin manifestations without neurological symptoms. We have previously suggested that these differences in clinical manifestations in XP‐D patients are attributed partly to a predominant mutation in ERCC2, and the allele frequency of S541R is highest in Japan.\",\"PeriodicalId\":20060,\"journal\":{\"name\":\"Photodermatology\",\"volume\":\"22 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Photodermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/phpp.12240\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photodermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/phpp.12240","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A 10‐year follow‐up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole‐genome sequencing
Most patients with xeroderma pigmentosum complementation group D (XP‐D) from Western countries suffer from neurological symptoms, whereas Japanese patients display only skin manifestations without neurological symptoms. We have previously suggested that these differences in clinical manifestations in XP‐D patients are attributed partly to a predominant mutation in ERCC2, and the allele frequency of S541R is highest in Japan.